Advanced search
Publication Cover
Annals of Medicine Volume 45, 2013 - Issue 4
Submit an article Journal homepage
2,612
Views
59
CrossRef citations to date
0
Altmetric
Review Article

Tocilizumab: A novel humanized anti-interleukin 6 (IL-6) receptor antibody for the treatment of patients with non-RA systemic, inflammatory rheumatic diseases

Rieke AltenSchlosspark-Klinik, University Medicine Berlin, Internal Medicine II, Rheumatology, Berlin, GermanyCorrespondence[email protected]
&
Tazio MaleitzkeSchlosspark-Klinik, University Medicine Berlin, Internal Medicine II, Rheumatology, Berlin, Germany
Pages 357-363 | Received 18 Jun 2012, Accepted 10 Dec 2012, Published online: 08 May 2013

Citations (59)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (10)

Santos Castañeda, Dolores Martínez-Quintanilla, José L. Martín-Varillas, Noelia García-Castañeda, Belén Atienza-Mateo & Miguel A. González-Gay. (2019) Tocilizumab for the treatment of adult-onset Still’s disease. Expert Opinion on Biological Therapy 19:4, pages 273-286.
Read now
Michael Schirmer, Francesco Muratore & Carlo Salvarani. (2018) Tocilizumab for the treatment of giant cell arteritis. Expert Review of Clinical Immunology 14:5, pages 339-349.
Read now
Dae Hyun Yoo. (2017) Treatment of adult-onset still’s disease: up to date. Expert Review of Clinical Immunology 13:9, pages 849-866.
Read now
Ryota Sakai, Tsuneo Kondo, Jun Kikuchi, Akiko Shibata, Kentaro Chino, Ayumi Okuyama, Hirofumi Takei & Koichi Amano. (2016) Corticosteroid-free treatment of tocilizumab monotherapy for microscopic polyangiitis: a single-arm, single-center, clinical trial. Modern Rheumatology 26:6, pages 900-907.
Read now
Chi Chiu Mok. (2016) Treat-to-target in systemic lupus erythematosus: are we there yet?. Expert Review of Clinical Pharmacology 9:5, pages 675-680.
Read now
Sabeeda Kadavath & Petros Efthimiou. (2015) Adult-onset Still's disease—pathogenesis, clinical manifestations, and new treatment options. Annals of Medicine 47:1, pages 6-14.
Read now
Emilio Besada. (2014) Potential patient benefit of a subcutaneous formulation of tocilizumab for the treatment of rheumatoid arthritis: a critical review. Patient Preference and Adherence 8, pages 1051-1059.
Read now
Feifan Yu, Lindvi Gudmundsdotter, Anastassja Akal, Elin Gunneriusson, Fredrik Frejd & Per-Åke Nygren. (2014) An affibody-adalimumab hybrid blocks combined IL-6 and TNF-triggered serum amyloid A secretion in vivo. mAbs 6:6, pages 1598-1607.
Read now
Rochella A. Ostrowski, Melissa R. Bussey, Rodney Tehrani & Walter Jay. (2014) Biologic Therapy for the Treatment of Giant Cell Arteritis. Neuro-Ophthalmology 38:3, pages 107-112.
Read now
Michael Maes, George Anderson, Marta Kubera & Michael Berk. (2014) Targeting classical IL-6 signalling or IL-6 trans-signalling in depression?. Expert Opinion on Therapeutic Targets 18:5, pages 495-512.
Read now

Articles from other publishers (49)

Shuhei Yoshida, Eiji Suzuki, Haruki Matsumoto, Kohei Yokose, Yuya Fujita, Jumpei Temmoku, Naoki Matsuoka, Makiko Yashiro-Furuya, Tomoyuki Asano, Shuzo Sato, Hiroshi Watanabe & Kiyoshi Migita. (2023) Effectiveness of combination tocilizumab and glucocorticoids as an induction therapy in patients with Takayasu arteritis: An observational study. Modern Rheumatology 33:2, pages 360-366.
Crossref
Pengbo Zhang & Huang Zhu. (2022) Cytokines in Thyroid-Associated Ophthalmopathy. Journal of Immunology Research 2022, pages 1-12.
Crossref
Gabriele Mandarelli, Florenzo Iannone, Stefano Ferracuti, Ignazio Grattagliano, Marcello Benevento, Biagio Solarino, Davide Ferorelli & Roberto Catanesi. (2022) Informed consent and biological agents in rheumatology and internal medicine. European Journal of Clinical Investigation 52:9.
Crossref
Mohammed Ahmed Akkaif, Abubakar Sha’aban, Arturo Cesaro, Ammar Ali Saleh Jaber, Andrea Vergara, Ismaeel Yunusa, Abubakar Ibrahim Jatau, Mustapha Mohammed, G. Saravana Govindasamy, Majed Ahmed Al-Mansoub, Muhamad Ali Sheikh Abdul Kader & Baharudin Ibrahim. (2022) The impact of SARS-CoV-2 treatment on the cardiovascular system: an updated review. Inflammopharmacology 30:4, pages 1143-1151.
Crossref
Xingyu Zhu, Liuyiqi Jiang, Qian Zhong, Xiangzhen Kong, Rui Zhang, Lingxian Zhu, Qingmei Liu, Wenyu Wu, Yimei Tan, Jiucun Wang & Jingjing Xia. (2022) Abnormal expression of interleukin-6 is associated with epidermal alternations in localized scleroderma. Clinical Rheumatology 41:7, pages 2179-2187.
Crossref
Mark Toshner, Colin Church, Lars Harbaum, Christopher Rhodes, Sofia S. Villar Moreschi, James Liley, Rowena Jones, Amit Arora, Ken Batai, Ankit A. Desai, John G. Coghlan, J. Simon R. Gibbs, Dee Gor, Stefan Gräf, Louise Harlow, Jules Hernandez-Sanchez, Luke S. Howard, Marc Humbert, Jason Karnes, David G. Kiely, Rick Kittles, Emily Knightbridge, Brian Lam, Katie A. Lutz, William C. Nichols, Michael W. Pauciulo, Joanna Pepke-Zaba, Jay Suntharalingam, Florent Soubrier, Richard C. Trembath, Tae-Hwi L. Schwantes-An, S. John Wort, Martin R. Wilkins, Sean Gaine, Nicholas W. Morrell & Paul A. Corris. (2022) Mendelian randomisation and experimental medicine approaches to interleukin-6 as a drug target in pulmonary arterial hypertension. European Respiratory Journal 59:3, pages 2002463.
Crossref
Monique Hinchcliff, Rolando Garcia-Milian, Stefano Di Donato, Karin Dill, Elizabeth Bundschuh & Francesco Del Galdo. (2021) Cellular and Molecular Diversity in Scleroderma. Seminars in Immunology 58, pages 101648.
Crossref
Zoltán Szekanecz, Iain B. McInnes, Georg Schett, Szilvia Szamosi, Szilvia Benkő & Gabriella Szűcs. (2021) Autoinflammation and autoimmunity across rheumatic and musculoskeletal diseases. Nature Reviews Rheumatology 17:10, pages 585-595.
Crossref
Sifan Wu, Xiufang Kong, Xiaomeng Cui, Huiyong Chen, Lili Ma, Xiaomin Dai, Zongfei Ji, Yan Yan, Qingrong Huang, Ying Sun & Lindi Jiang. (2021) Effectiveness and safety of tocilizumab in patients with refractory or severe Takayasu's arteritis: A prospective cohort study in a Chinese population. Joint Bone Spine 88:5, pages 105186.
Crossref
Li Zheng, Fanlei Hu, Wenjie Bian, Yingni Li, Linqi Zhang, Lianjie Shi, Xiaoxu Ma, Yanying Liu, Xuewu Zhang & Zhanguo Li. (2021) Dickkopf-1 perpetuated synovial fibroblast activation and synovial angiogenesis in rheumatoid arthritis. Clinical Rheumatology 40:10, pages 4279-4288.
Crossref
Marc Dinkin & Editha Johnson. (2021) One Giant Step for Giant Cell Arteritis: Updates in Diagnosis and Treatment. Current Treatment Options in Neurology 23:2.
Crossref
Shuxin Liang, Ankit A. Desai, Stephen M. Black & Haiyang Tang. 2021. Lung Inflammation in Health and Disease, Volume I. Lung Inflammation in Health and Disease, Volume I 275 303 .
Robert W. Simms. (2020) Expert Perspectives On Clinical Challenges: Expert Perspectives: Challenges in Scleroderma. Arthritis & Rheumatology 72:9, pages 1415-1426.
Crossref
Jae B. Park, Renee Peters, Quynhchi Pham & Thomas T. Y. Wang. (2020) Javamide-II Inhibits IL-6 without Significant Impact on TNF-alpha and IL-1beta in Macrophage-Like Cells. Biomedicines 8:6, pages 138.
Crossref
Yuri Clement, Satish Jankie, Shalini Pooransingh, Diane Ignacio, Avril Reid, Shurla Sampson-FrancisStanley Giddings & Harold Watson. (2020) A literature review of drugs for the treatment of COVID-19. Caribbean Medical Journal.
Crossref
Nicholas Kevin Laidler & Thomas Delaney. (2020) Remitting seronegative symmetric synovitis with pitting edema (RS3PE) with painful erythematous nodules. BMJ Case Reports 13:4, pages e234197.
Crossref
Dominic S. Raj, Roberto Pecoits-Filho & Paul L. Kimmel. 2020. Chronic Renal Disease. Chronic Renal Disease 355 373 .
Marcin Smreczak, Anna Marzec, Anna Orłowska, Paweł Trębas, Michał Reichert, Anna Kycko, Penelopa Koraka, Ab Osterhaus & Jan Franciszek Żmudziński. (2019) The effect of selected molecules influencing the detrimental host immune response on a course of rabies virus infection in a murine model. Vaccine 37:33, pages 4715-4723.
Crossref
Ahmet Ilbay, Abdulsamet Erden, Alper Sari, Berkan Armagan, Burak Yasin Aktas, Ertugrul Cagri Bolek, Umut Kalyoncu & Omer Karadag. (2019) Successful Treatment of Amyloid A–Type Amyloidosis Due to Behçet Disease With Tocilizumab. JCR: Journal of Clinical Rheumatology 25:4, pages e43-e45.
Crossref
Annemarie Schorpion, Reshmi Raveendran, Anupama Shahane, Mildred Kwan & Alfredo C. Rivadeneira. 2019. Rare Rheumatic Diseases of Immunologic Dysregulation. Rare Rheumatic Diseases of Immunologic Dysregulation 139 155 .
Menglin Fan, Yanan Li, Chunhua Yao, Xiufeng Liu, Xuming Liu & Jihua Liu. (2018) Dihydroartemisinin derivative DC32 attenuates collagen-induced arthritis in mice by restoring the Treg/Th17 balance and inhibiting synovitis through down-regulation of IL-6. International Immunopharmacology 65, pages 233-243.
Crossref
Tanaz A Kermani & Bhaskar Dasgupta. (2018) Current and emerging therapies in large-vessel vasculitis. Rheumatology 57:9, pages 1513-1524.
Crossref
Galia Zacay & Yair Levy. (2018) Outcomes of patients with systemic sclerosis treated with tocilizumab: Case series and review of the literature. Best Practice & Research Clinical Rheumatology 32:4, pages 563-571.
Crossref
Jones Gyamfi, Minseob Eom, Ja-Seung Koo & Junjeong Choi. (2018) Multifaceted Roles of Interleukin-6 in Adipocyte–Breast Cancer Cell Interaction. Translational Oncology 11:2, pages 275-285.
Crossref
Jules Hernández‐Sánchez, Louise Harlow, Colin Church, Sean Gaine, Emily Knightbridge, Kate Bunclark, Dee Gor, Alun Bedding, Nicholas Morrell, Paul Corris & Mark Toshner. (2017) Clinical trial protocol for TRANSFORM‐UK: A therapeutic open‐label study of tocilizumab in the treatment of pulmonary arterial hypertension. Pulmonary Circulation 8:1, pages 1-8.
Crossref
DH Yang. (2017) The Biological Effects of Interleukin-6 and Their Clinical Applications in Autoimmune Diseases and Cancers. Rheumatica Acta: Open Access 1:1, pages 006-016.
Crossref
Sebastian Volc, Kamran Ghoreschi & Hui Shen. 2017. Practical Immunodermatology. Practical Immunodermatology 367 381 .
Robert W. Simms. 2017. Scleroderma. Scleroderma 489 498 .
Alex Klarenbeek, Christophe Blanchetot, Georg Schragel, Ava S. Sadi, Nico Ongenae, Wieger Hemrika, John Wijdenes, Silvia Spinelli, Aline Desmyter, Christian Cambillau, Anna Hultberg, Anke Kretz-Rommel, Torsten Dreier, Hans J.W. De Haard & Rob C. Roovers. (2016) Combining somatic mutations present in different in vivo affinity-matured antibodies isolated from immunized Lama glama yields ultra-potent antibody therapeutics . Protein Engineering Design and Selection 29:4, pages 123-133.
Crossref
Jeffrey T. Guptill, Madhu Soni & Matthew N. Meriggioli. (2015) Current Treatment, Emerging Translational Therapies, and New Therapeutic Targets for Autoimmune Myasthenia Gravis. Neurotherapeutics 13:1, pages 118-131.
Crossref
John Anthonypillai & Julian L. Ambrus. 2016. Systemic Vasculitides: Current Status and Perspectives. Systemic Vasculitides: Current Status and Perspectives 407 423 .
Francisco Espinoza, Christian Jorgensen & Yves-Marie Pers. (2015) Efficacité du tocilizumab dans un cas de fasciite à éosinophiles. Revue du Rhumatisme 82:6, pages 414-415.
Crossref
Francisco Espinoza, Christian Jorgensen & Yves-Marie Pers. (2015) Efficacy of Tocilizumab in the treatment of Eosinophilic fasciitis: Report of one case. Joint Bone Spine 82:6, pages 460-461.
Crossref
Manfred Relle, Julia Weinmann-Menke, Eva Scorletti, Lorenzo Cavagna & Andreas Schwarting. (2015) Genetics and novel aspects of therapies in systemic lupus erythematosus. Autoimmunity Reviews 14:11, pages 1005-1018.
Crossref
Daniela Rossi, Vittorio Modena, Savino Sciascia & Dario Roccatello. (2015) Rheumatoid arthritis: Biological therapy other than anti-TNF. International Immunopharmacology 27:2, pages 185-188.
Crossref
Jean-Marc Cavaillon. 2006. Reviews in Cell Biology and Molecular Medicine. Reviews in Cell Biology and Molecular Medicine 1 37 .
B. Coiffard, S. Laroumagne, J. Plojoux, P. Astoul & H. Dutau. (2015) Un collapsus expiratoire diffus et circonférentiel. Revue des Maladies Respiratoires 32:3, pages 296-300.
Crossref
Benjamin Wolfson. (2015) Adipocyte activation of cancer stem cell signaling in breast cancer. World Journal of Biological Chemistry 6:2, pages 39.
Crossref
Dominic S. Raj, Roberto Pecoits-Filho & Paul L. Kimmel. 2015. Chronic Renal Disease. Chronic Renal Disease 199 212 .
Naeun Lee, Sungyong You, Min Sun Shin, Won-Woo Lee, Ki Soo Kang, Sang Hyun Kim, Wan-Uk Kim, Robert J. Homer, Min-Jong Kang, Ruth R. Montgomery, Charles S. Dela Cruz, Albert C. Shaw, Patty J. Lee, Geoffrey L. Chupp, Daehee Hwang & Insoo Kang. (2014) IL-6 Receptor α Defines Effector Memory CD8 + T Cells Producing Th2 Cytokines and Expanding in Asthma . American Journal of Respiratory and Critical Care Medicine 190:12, pages 1383-1394.
Crossref
Marco Sisignano, Ralf Baron, Klaus Scholich & Gerd Geisslinger. (2014) Mechanism-based treatment for chemotherapy-induced peripheral neuropathic pain. Nature Reviews Neurology 10:12, pages 694-707.
Crossref
Marina Mesquida, Blanca Molins, Victor Llorenç, Maite Sainz de la Maza & Alfredo Adán. (2014) Long-Term Effects of Tocilizumab Therapy for Refractory Uveitis-Related Macular Edema. Ophthalmology 121:12, pages 2380-2386.
Crossref
C. Le Stradic, C. Galeotti & I. Koné-Paut. (2014) Traitement par tocilizumab : expérience d’un centre de rhumatologie pédiatrique. Archives de Pédiatrie 21:12, pages 1299-1304.
Crossref
M Mesquida, A Leszczynska, V Llorenç & A Adán. (2014) Interleukin-6 blockade in ocular inflammatory diseases. Clinical and Experimental Immunology 176:3, pages 301-309.
Crossref
Tanaz A. Kermani & Kenneth J. Warrington. (2013) Advances and challenges in the diagnosis and treatment of polymyalgia rheumatica. Therapeutic Advances in Musculoskeletal Disease 6:1, pages 8-19.
Crossref
Xin Yao, Jiaqi Huang, Haihong Zhong, Nan Shen, Raffaella Faggioni, Michael Fung & Yihong Yao. (2014) Targeting interleukin-6 in inflammatory autoimmune diseases and cancers. Pharmacology & Therapeutics 141:2, pages 125-139.
Crossref
Francesca Ingegnoli, Athanasia Tourlaki & Roberta Gualtierotti. (2013) Tocilizumab Monotherapy in a Patient with Rheumatoid Arthritis and Iatrogenic Kaposi Sarcoma. Clinical Drug Investigation 34:2, pages 159-161.
Crossref
Alison Clifford & Gary S. Hoffman. (2014) Recent advances in the medical management of Takayasu arteritis. Current Opinion in Rheumatology 26:1, pages 7-15.
Crossref
Noémie Abisror, Arsene Mekinian, Christian Lavigne, Marie-Anne Vandenhende, Michael Soussan & Olivier Fain. (2013) Tocilizumab in refractory Takayasu arteritis: A case series and updated literature review. Autoimmunity Reviews 12:12, pages 1143-1149.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.